

De Haar Research Task Force | Foundation (DHRF)
The Hague - Amsterdam, The Netherlands
Fostering High-Quality Honest & Fair Research Perfectionism
DHRF is an independent biomedical and cardiovascular think tank focused on pioneering advanced cardiovascular care and imaging through the development of innovative medical technologies powered by artificial intelligence

Our Mission
At DHRF (De Haar Research Task Force), an independent biomedical and cardiovascular think tank, we advance translational and clinical cardiovascular research by integrating expert imaging, artificial intelligence, biomedical engineering, and nanomedicine into next-generation diagnostic and therapeutic solutions.
We actively develop cardiovascular AI ecosystems through strategic collaborations with leading AI and imaging companies in the United States and the Netherlands, including Mercor, Outlier, and Medis Medical Imaging.
Our AI work spans multiple domains: physician-in-the-loop model training, clinical reasoning alignment, reinforcement learning from expert feedback (RLHF), multimodal medical AI, and annotation-driven training for advanced imaging and physiological signal interpretation.
We contribute to the development of large language models and multimodal systems capable of complex cardiovascular decision-making, including medication reconciliation, discharge planning, acute coronary syndrome triage, heart failure management, risk stratification, and multidisciplinary care coordination.
A core focus is ECG-centered AI, where electrophysiological signals are integrated into broader diagnostic and prognostic frameworks for mortality prediction, urgency assessment, arrhythmia detection, and therapeutic planning.
In advanced imaging, DHRF supports AI innovation across CT, MRI, echocardiography, coronary angiography, IVUS, and OCT, including segmentation, plaque characterization, structural boundary detection, quantitative flow analysis, and anatomical modeling.
Through research, education, and global collaboration, DHRF helps shape future standards in cardiovascular medicine, building safer, more precise, and clinically actionable AI-driven healthcare systems.


The idea of DHRF was born in Rotterdam on February 15th, 2013. The DHRF develops and supports innovations in interventional cardiology, medical device development, intracoronary/ intravascular (QCA, IVUS, OCT, NIRS, photoacoustic), and non-invasive imaging (CCTA, CMR, MPI, PET, TTE), including artificial intelligence-based technologies, biomedical engineering, neurophysiology (primarily, consciousness), and nanomedicine (multifunctional nanoparticles for theranostics of atherosclerosis). The DHRF provides start-ups and small enterprises in the Netherlands, and the United States with the relevant research service and assistance in representing, promoting, and supporting their biomedical business in Europe, as well as the relevant translational and clinical studies including CE mark procedures. We do not collaborate with Russian institutions.
